Category Pharmacists

Smoldering-associated worsening (SAW) of multiple sclerosis (MS) deserves a broader, more comprehensive approach to diagnosis, treatment, and research that goes beyond neurologists’ understanding of progression independent of relapse activity (PIRA), according to a recently published international consensus. However, an outside…

Over the past few years, osimertinib has received much fanfare among lung cancer experts.  Results from the phase 3 LAURA trial were met with a standing ovation at the 2024 American Society of Clinical Oncology annual meeting, after the trial…